Duchesnay USA Revenue and Competitors
Estimated Revenue & Valuation
- Duchesnay USA's estimated annual revenue is currently $4.2M per year.
- Duchesnay USA's estimated revenue per employee is $201,000
Employee Data
- Duchesnay USA has 21 Employees.
- Duchesnay USA grew their employee count by -16% last year.
Duchesnay USA's People
Name | Title | Email/Phone |
---|---|---|
1 | EVP | Reveal Email/Phone |
2 | Product Manager | Reveal Email/Phone |
3 | Hybrid Sales Specialist | Reveal Email/Phone |
Duchesnay USA Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $43.2M | 215 | 6% | N/A | N/A |
#2 | $81.8M | 407 | 10% | N/A | N/A |
#3 | $11.7M | 58 | 0% | N/A | N/A |
#4 | $1011.8M | 5034 | -9% | N/A | N/A |
#5 | $44.8M | 223 | 1% | N/A | N/A |
#6 | $13.1M | 65 | 5% | N/A | N/A |
#7 | $16.5M | 82 | 41% | N/A | N/A |
#8 | $17.3M | 86 | -5% | N/A | N/A |
#9 | $67.9M | 338 | 23% | N/A | N/A |
#10 | $14.9M | 74 | 7% | N/A | N/A |
What Is Duchesnay USA?
Duchesnay USA is a specialty pharmaceutical company with a long-standing commitment to women’s health. Until recently, we focused on filling the void in terms of scientific research and education and on developing pharmacological solutions that are safe and effective for use during pregnancy and breastfeeding. Today, Duchesnay has broadened its portfolio of products to offer safe and effective therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives. For more information about Duchesnay USA, please visit www.DuchesnayUSA.com.
keywords:N/AN/A
Total Funding
21
Number of Employees
$4.2M
Revenue (est)
-16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.1M | 21 | -12% | N/A |
#2 | $4.3M | 25 | 4% | N/A |
#3 | $15M | 25 | 9% | N/A |
#4 | $5.7M | 25 | 0% | N/A |
#5 | $3.5M | 26 | -13% | N/A |